Dr. Heist is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
32 Fruit St
Yawkey 7B
Boston, MA 02114Phone+1 617-724-4000Fax+1 617-726-0453- Is this information wrong?
Summary
- Dr. Rebecca Heist is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital. She received her medical degree from Harvard Medical School and has been in practice 18 years. She specializes in thoracic cancer and is experienced in the treatment of lung cancer, with a special focus on clinical trials of novel agents.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2005
Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2002
Harvard Medical SchoolClass of 1999
Certifications & Licensure
MA State Medical License 2001 - 2024- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2008 Apr 01
- Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2008 Apr 15
- Safety, Pharmacokinetics (PK) of AKT and MEK Combination Start of enrollment: 2010 May 04
- Join now to see all
Publications & Presentations
PubMed
- Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan.Toshio Shimizu, Noboru Yamamoto, Takahiro Kogawa, Francesca Pisetzky, Priyanka Basak, Cindy Lau, Rebecca S Heist, Jacob Sands, Aditya Bardia, Aaron Lisberg, Ian Krop, ...> ;Cancer Treatment Reviews. 2024 Apr 1
- Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.Kim, A., Lou, K., Giobbie-Hurder, A., Chang, K., Gidwani, M., Hoebel, K., Patel, J., Cleveland, M., Singh, P., Bridge, C., Ahmed, S., Bearce, B., Liu, W., Fuster-Garci...> ;Neuro-Oncology. 2023 Dec 9
- 3 citationsEfficacy and Tolerability of/Combinations in Patients With-Rearranged Lung Cancer With AcquiredAmplification: A Retrospective Analysis.Ibiayi Dagogo-Jack, Lesli A Kiedrowski, Rebecca S Heist, Jessica J Lin, Catherine B Meador, Elizabeth A Krueger, Andrew Do, Jennifer Peterson, Lecia V Sequist, Justin ...> ;JTO Clinical and Research Reports. 2023 Aug 1
- Join now to see all
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationR S Heist, Z Piotrowska, C G Azzoli, A T Shaw, I T Lennes, L V Sequist, J F Gainor, Oxford University Press
Press Mentions
Coronavirus Slowing Critical Cancer Research, ScreeningsDecember 21st, 2020
Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study of AG-270, a MAT2A Inhibitor, in Patients with MTAP-Deleted TumorsOctober 27th, 2019
Capmatinib Trial Targets New Molecular Subsets of Patients in NSCLCJuly 4th, 2016- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
